Search

everythinglearnresearchcommunity

for

Search:↓

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Stress hormone CRF causes hair loss and stops hair cell growth.

Corticosterone makes ethanol more effective at blocking brain processes important for learning and memory.

A natural steroid in the body may protect against eye damage in glaucoma.

Topical corticosteroid was not more effective than placebo for children's alopecia areata, and atopy did not change treatment results.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Canine hair follicle cells metabolize DHEA and testosterone differently than human cells.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

The anterior pituitary controls adrenal cortex size and activity through ACTH.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Hair cortisol measurement can help diagnose and monitor Cushing’s disease.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Vitamin B12 and aureomycin can reverse or reduce cortisone's negative effects on body and hair growth in rats.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

The rapid corticotropin test is a quick and simple way to diagnose adrenal insufficiency.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Inhaled steroids in children may cause excessive hair growth and not always go away after stopping the medication.

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Triple H syndrome exists and can vary in symptoms.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.